查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1986618

北美生物再生美容注射市场：市场规模、份额和趋势分析（按产品、应用、最终用途和地区划分），细分市场预测（2026-2033 年）

North America Bioregenerative Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product (PN, Peptide-based Injectables), By Application, By End Use (MedSpas, Aesthetic Surgery Centers), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

北美生物再生美容注射市场概述

预计到 2025 年，北美生物再生美容注射市场价值将达到 4.978 亿美元，到 2033 年将达到 11.6 亿美元，2026 年至 2033 年的复合年增长率为 11.2%。

这一增长是由消费者对天然、隐藏、微创的护肤疗法的需求不断增长所驱动的，这些疗法能够促进皮肤的长期健康。

富血小板血浆（PRP）、多核苷酸和外泌体等再生技术的进步正在提升这些产品的功效。全球意识的提高、可支配收入的增加以及医疗和美容基础设施的不断完善，进一步推动了这些产品在主要市场的普及。在美国，消费者对生物再生美容注射的需求源于对健康日益增长的关注，以及对「天然」或自体疗法的强烈偏好，这些疗法侧重于组织修復而非仅仅遮盖瑕疵。高所得的都市区专业人士将美容疗程视为自我护理的一部分，因此这些疗法的普及率最高。

他们更倾向于微创、可重复的疗程，例如富血小板血浆（PRP）、胜肽类增效剂和外泌体增效剂。诊所的疗效、病患口碑以及社群媒体上的意见领袖都会影响他们的选择。强调再生、癒合和生物製剂的讯息能够引起那些对合成植入持谨慎态度，但愿意投资于长期皮肤健康的人们的共鸣。在美国，对微创注射疗法的需求持续成长。专家数据显示，这些疗程的数量略有上升，全球调查显示，美国在美容手术总量方面位居世界第一，这表明美国此类疗程供应充足，且患者对其较为熟悉。

庞大的劳动年龄人口是聚乳酸（PLLA）填充剂需求的主要驱动力。根据加拿大统计局（2024年9月）的数据，加拿大的中位数年龄为40.3岁，20至65岁之间的人群中有相当一部分正在积极寻求解决皱纹、皮肤鬆弛和容量流失等问题的方法。 PLLA填充剂是这群人的首选，因为它能刺激体内胶原蛋白的合成，带来渐进且自然的改善效果。同时，根据美国人口普查局（2023年5月）的数据，美国老年人口（约占65岁以上人口的六分之一）也越来越倾向于寻求再生美容解决方案来对抗与老龄化相关的皮肤变化，这进一步推动了市场成长。此外，美国拥有世界上最高的整形外科医生密度之一，注射类产品的普及程度也很高，这进一步增强了该市场的成长潜力。

与美国患者相比，加拿大患者在使用生物再生注射疗法时往往更为谨慎。他们的决定主要受皮肤科医生和整形外科医生等临床医生的指导，这些医生通常透过转诊获得。此外，加拿大社会对医疗合法性的认知也更为严格，这也会影响他们的决定。由于许多加拿大人依赖全民健保系统进行基层医疗保健，因此选择性美容手术大多属于自愿性质，需要自费，并且主要在多伦多、温哥华和蒙特利尔等都市区进行，因为这些地区集中了专业的诊所和皮肤科医生。

儘管富血小板血浆（PRP）等再生医学疗法已逐渐普及，但由于其监管存在地域差异（例如，加拿大卫生署负责监管自体血液製品），因此人们对明确的安全性和有效性证据的需求日益增长。在这种法规环境下，患者往往更倾向于选择由诊所主导、以实证医学为基础的治疗方案，而非盲目追随社群媒体上的趋势。因此，先进的再生医学注射技术正缓慢但稳定地推广应用，患者在选择外泌体和肽类疗法时，会优先考虑医生的声誉、已发表的证据以及透明的安全措施。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：北美生物再生美容注射市场：影响因素、趋势和范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 北美生物再生美容注射市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
  • 生物再生美容注射市场概况（北美市场规模（估计值），按地区划分，2025 年）
  • 消费行为分析
  • 从业者/服务提供者展望
    • 预计各国美容注射产品专业人员及供应商数（2024/25 年及以后）
    • 提供注射治疗的前 3-5 名的专家：按国家/地区划分

第四章：北美生物再生美容注射市场：按产品分類的估算与趋势分析

  • 北美生物再生美容注射市场：产品概览
  • 北美生物再生美容注射市场：按产品分類的波动分析（2021-2033 年）
  • 北美生物再生美容注射市场：按产品分類的收入（2021-2033 年）
  • PN
    • PDRN
    • PN注射
  • 基于胜肽的注射药物
  • 基于外泌体的注射药物
  • 生物刺激剂注射
    • PLLA
    • CaHA
  • PRP製备
  • 其他的

第五章：北美生物再生美容注射市场：按应用分類的估算和趋势分析

  • 北美生物再生美容注射市场：产品概览
  • 北美生物再生美容注射市场：按应用领域分類的波动分析（2021-2033 年）
  • 北美生物再生美容注射市场估计与预测：按应用领域分類的收入（2021-2033 年）
  • 肌肤补水保湿（脸部）
  • 弹性和紧緻度（脸部）
  • 眼部区域（脸部）
  • 细纹（脸部）
  • 痤疮疤痕（脸部）
  • 改善脸部皱纹
  • 身体护理
    • 手臂和大腿
    • 低胸装
    • 敏感区域
    • 膝盖
    • 头皮和头髮再生

第六章：北美生物再生美容注射市场：按最终用途分類的估算和趋势分析

  • 北美生物再生美容注射市场：按最终用途分類的概览
  • 北美生物再生美容注射市场：按最终用途分類的波动分析（2021-2033 年）
  • 北美生物再生美容注射市场估计与预测：按最终用途分類的收入（2021-2033 年）
  • 医疗水疗中心
  • 整形外科中心
  • 医院
  • 皮肤病中心
  • 其他的

第七章：北美生物再生美容注射市场：区域估算和趋势分析（按产品、应用和最终用途划分）

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大

第八章 竞争情势

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商和通路合作伙伴名单
    • 主要企业市占率分析（2025 年）
    • PharmaResearch Products Co., Ltd.
    • MD Skin Solutions
    • Mastelli srl
    • Merz Aesthetics
    • Caregen Co. Ltd
    • Croma Pharma
    • PROMOITALIA
    • Galderma
    • Fillmed
    • IBSA
    • Bio-Formula
    • BR Pharma
    • Allergan（AbbVie）
    • Merz
    • Fidia
    • VAIM
Product Code: GVR-4-68040-850-1

North America Bioregenerative Aesthetic Injectable Market Summary

The North America bioregenerative aesthetic injectable market size was estimated at USD 497.8 million in 2025 and is projected to reach USD 1,160.0 million by 2033, growing at a CAGR of 11.2% from 2026 to 2033. This growth is driven by rising consumer demand for natural-looking, minimally invasive treatments that promote long-term skin health.

Advances in regenerative technologies like platelet-rich plasma, polynucleotides, and exosomes are boosting product effectiveness. Increasing awareness, higher disposable incomes, and expanding medical aesthetics infrastructure worldwide are further driving adoption across key markets. In the U.S., consumer behavior toward bioregenerative aesthetic injectables is driven by a wellness focus and a strong preference for "natural" or autologous options that emphasize tissue repair rather than merely hiding imperfections. Adoption is highest among urban professionals in higher-income brackets who view aesthetic treatments as part of their self-care routine.

They prefer minimally invasive procedures that can be repeated, such as PRP, peptide-based boosters, and exosome boosters. Clinic results, patient reviews, and social media influencers shape their choices. Messaging highlights regeneration, healing, and biologics, resonates with those cautious about synthetic implants yet willing to spend on long-term skin health. The U.S. continues to see growth in minimally invasive injectables. Professional data show a slight increase in these treatments, and global surveys rank the U.S. as the leader in total aesthetic procedures, indicating a strong supply and patient familiarity.

The prevalent working-age population significantly fuels the demand for PLLA fillers. According to Statistics Canada (September 2024), the median age in Canada is 40.3 years, with a substantial portion aged 20-65 actively seeking solutions to address wrinkles, sagging, and volume loss. PLLA fillers provide gradual, natural-looking improvements by stimulating endogenous collagen synthesis, making them a favorable option for this demographic. In parallel, the U.S. geriatric population, approximately 1 in 6 individuals above 65, as per the U.S. Census Bureau (May 2023), increasingly seeks regenerative aesthetic solutions to counteract age-related skin changes, further propelling market growth. The U.S. also has the highest concentration of plastic surgeons globally, creating widespread access to advanced injectables and reinforcing the market's expansion potential.

Canadian patients tend to use bioregenerative injectables more cautiously than their U.S. counterparts. Their decisions are mainly guided by clinicians, such as dermatologists and plastic surgeons, recommended through referrals and influenced by stricter public perceptions of medical legitimacy. Since many Canadians rely on a universal health system for primary care, elective aesthetic procedures are largely discretionary, paid out-of-pocket, and mainly performed in urban areas like Toronto, Vancouver, and Montreal, where specialist clinics and dermatologists are concentrated.

Popular regenerative treatments like PRP are well-established, but they are regulated locally (Health Canada oversees autologous blood products), which increases the demand for clear safety and effectiveness evidence. This regulatory environment encourages patients to prefer clinic-led, evidence-supported treatments over social-media trends. As a result, the adoption of advanced regenerative injectables occurs more slowly but consistently, with patients emphasizing physician reputation, published evidence, and transparent safety measures when selecting exosome or peptide therapies.

North America Bioregenerative Aesthetic Injectable Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America bioregenerative aesthetic injectable market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • PN
    • PDRN
    • PN Injectables
  • Peptide-based Injectables
  • Exosome-based Injectables
  • Biostimulatory Injectables
    • PLLA
    • CaHA
  • PRP Injectables
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Skin Hydration & Moisturization (For Face)
  • Elasticity & Firmness (For Face)
  • Under eye-areas (For Face)
  • Fine Lines (For Face)
  • Acne Scar (For Face)
  • Wrinkle Correction (For Face)
  • Body Application
    • Arms & Thighs
    • Decolletage
    • Intimate Areas
    • Knees
    • Scalp & Hair Rejuvenation
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpas
  • Aesthetic Surgery Centers
  • Hospitals
  • Dermatology Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Bioregenerative Aesthetic Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. North America Bioregenerative Aesthetic Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
  • 3.4. Topline Overview of the Bioregenerative Aesthetic Injectable Market (Market Size, by Region, Topline Estimated for North America, 2025)
  • 3.5. Consumer Behavior Analysis
  • 3.6. Practitioner/Provider Outlook
    • 3.6.1. Estimated Number of Professionals/ Providers Administering Aesthetic Injectable Product by Country, for 2024/25-
      • 3.6.1.1. U.S.
      • 3.6.1.2. Canada
    • 3.6.2. Three to Five Key Professionals Offering an Injectable Procedure, by Country-
      • 3.6.2.1. U.S.
      • 3.6.2.2. Canada

Chapter 4. North America Bioregenerative Aesthetic Injectable Market: Product Estimates & Trend Analysis

  • 4.1. North America Bioregenerative Aesthetic Injectable Market: Product Dashboard
  • 4.2. North America Bioregenerative Aesthetic Injectable Market: Product Movement Analysis, 2021 to 2033 (USD Million)
  • 4.3. North America Bioregenerative Aesthetic Injectable Market by Product, Revenue, 2021 to 2033 (USD Million)
  • 4.4. PN
    • 4.4.1. PN market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. PDRN
      • 4.4.2.1. PDRN market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. PN Injectable
      • 4.4.3.1. PN injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Peptide-based Injectables
    • 4.5.1. Peptide-based injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Exosome-based injectables
    • 4.6.1. Exosome-based injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Biostimulatory Injectables
    • 4.7.1. Biostimulatory injectables market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. PLLA
      • 4.7.2.1. PLLA market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. CaHA
      • 4.7.3.1. CaHA market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. PRP Injectables
    • 4.8.1. PRP Injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Bioregenerative Aesthetic Injectable Market: Application Estimates & Trend Analysis

  • 5.1. North America Bioregenerative Aesthetic Injectable Market: Application Dashboard
  • 5.2. North America Bioregenerative Aesthetic Injectable Market: Application Movement Analysis, 2021 to 2033 (USD Million)
  • 5.3. North America Bioregenerative Aesthetic Injectable Market Estimates and Forecasts, By Application, Revenue, 2021 to 2033 (USD Million)
  • 5.4. Skin Hydration & Moisturization (For Face)
    • 5.4.1. Skin Hydration & Moisturization (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.5. Elasticity & Firmness (For Face)
    • 5.5.1. Elasticity & Firmness (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.6. Under eye-areas (For Face)
    • 5.6.1. Under eye-areas (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.7. Fine Lines (For Face)
    • 5.7.1. Fine Lines (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.8. Acne Scar (For Face)
    • 5.8.1. Acne Scar (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.9. Wrinkle Correction (For Face)
    • 5.9.1. Wrinkle Correction (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.10. Body Application
    • 5.10.1. Body Application market estimates and forecasts for 2021 - 2033 (USD Million)
    • 5.10.2. Arms & Thighs
      • 5.10.2.1. Arms & Thighs market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.3. Decolletage
      • 5.10.3.1. Decolletage market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.4. Intimate Areas
      • 5.10.4.1. Intimate Areas market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.5. Knees
      • 5.10.5.1. Knees market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.6. Scalp & Hair Rejuvenation
      • 5.10.6.1. Scalp & Hair Rejuvenation market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Bioregenerative Aesthetic Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. North America Bioregenerative Aesthetic Injectable Market: End Use Dashboard
  • 6.2. North America Bioregenerative Aesthetic Injectable Market: End Use Movement Analysis, 2021 to 2033 (USD Million)
  • 6.3. North America Bioregenerative Aesthetic Injectable Market Estimates and Forecasts, By End Use, Revenue, 2021 to 2033 (USD Million)
  • 6.4. MedSpas
    • 6.4.1. MedSpas market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.5. Aesthetic Surgery Centers
    • 6.5.1. Aesthetic Surgery Centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.7. Dermatology Centers
    • 6.7.1. Dermatology Centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 7. North America Bioregenerative Aesthetic Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.1.5. Key Cosmetic Polynucleotides Brands Available in the U.S. (This analysis is specific to the U.S. only)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2025
    • 8.2.3. PharmaResearch Products Co., Ltd.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. MD Skin Solutions
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Mastelli s.r.l.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merz Aesthetics
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Caregen Co. Ltd
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Croma Pharma
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. PROMOITALIA
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Galderma
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Fillmed
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. IBSA
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Bio-Formula
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. BR Pharma
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Allergan (AbbVie)
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. Merz
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. Fidia
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. VAIM
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America bioregenerative aesthetic injectable market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 North America Bioregenerative Aesthetic Injectable Market: Market Outlook
  • Fig. 7 North America Bioregenerative Aesthetic Injectables Competitive Insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 North America Bioregenerative Aesthetic Injectable Market Driver Impact
  • Fig. 11 North America Bioregenerative Aesthetic Injectable Market Restraint Impact
  • Fig. 12 North America Bioregenerative Aesthetic Injectable Market: Product movement analysis
  • Fig. 13 North America Bioregenerative Aesthetic Injectable Market: Product outlook and key takeaways
  • Fig. 14 PN market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 PDRN market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 PN injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Peptide-based injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Exosome-based injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Biostimulatory injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 PLLA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 CaHA lens market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 PRP injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Other market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 North America Bioregenerative Aesthetic Injectable Market: Application movement analysis
  • Fig. 25 North America Bioregenerative Aesthetic Injectable Market: Application outlook and key takeaways
  • Fig. 26 Skin hydration & moisturization (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Elasticity & firmness (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Under eye-areas (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Fine lines (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Acne scar (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Wrinkle correction (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Body application market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Arms & thighs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Decolletage market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Intimate areas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Knees market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Scalp & hair rejuvenation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 North America Bioregenerative Aesthetic Injectable Market: End Use movement analysis
  • Fig. 39 North America Bioregenerative Aesthetic Injectable Market: End Use outlook and key takeaways
  • Fig. 40 MedSpas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Aesthetic surgery centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Dermatology centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 North America Bioregenerative Aesthetic Injectable Market: Regional movement analysis
  • Fig. 46 North America Bioregenerative Aesthetic Injectable Market: Regional outlook and key takeaways
  • Fig. 47 North America Bioregenerative Aesthetic Injectable Market share and leading players
  • Fig. 48 North America, by country
  • Fig. 49 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 U.S. key country dynamics
  • Fig. 51 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Canada key country dynamics
  • Fig. 53 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Market share of key market players- Bioregenerative Aesthetic Injectable Market